Researchers are exploring advanced nanomedicine approaches for the treatment of myocardial infarction, with a focus on targeted therapy and drug delivery systems. These approaches aim to address inflammatory immune mechanisms and oxidative stress associated with the condition. The development of nanomaterials and nanoparticle-based systems is being investigated for their potential to alleviate myocardial infarction and related vascular diseases.